TITLE:
Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)

CONDITION:
Hypercholesterolemia

INTERVENTION:
MK0653, ezetimibe

SUMMARY:

      This study will evaluate patients who have coronary heart disease to determine if an
      investigational drug will further lower cholesterol when taken in combination with an
      approved cholesterol lowering medication.
    

DETAILED DESCRIPTION:

      The duration of treatment is 10 weeks.
    

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Patients with elevated cholesterol and coronary heart disease

        Exclusion Criteria:

          -  Patients who do not meet specific cholesterol levels as required by the study
      
